A machine learning-based prognostic model for de novo metastatic HR-positive breast cancer: SEER cohort with external validation - Quiz - MDSpire

A machine learning-based prognostic model for de novo metastatic HR-positive breast cancer: SEER cohort with external validation

  • By

  • Sihang Lin

  • Wanwan Wang

  • Lixia Liu

  • Jiayu Guan

  • Chuanrong Cen

  • Huawei Yang

  • July 17, 2026

Share

Original Source(s)

A machine learning-based prognostic model for de novo metastatic HR-positive breast cancer: SEER cohort with external validation

  • by Sihang Lin, Wanwan Wang, Lixia Liu, Jiayu Guan, Chuanrong Cen, Huawei Yang

  • July 17, 2026

Related Content

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

Actinium-225-rhPSMA-10.1 as a novel, alpha-particle-emitting therapy for prostate cancer: results of a preclinical evaluation

An updated review on the role of extracellular vesicles in immune system modulation in breast cancer with special emphasis on immune checkpoint regulators